跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
侯 甚光
副教授
,
急診學科
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0002-7011-9088
電子郵件
992001
h.tmu.edu
tw
h-index
636
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2026
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(49)
類似的個人檔案
(6)
指紋
查看啟用 Sen-Kuang Hou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Cholecystitis
37%
Acute Kidney Injury
18%
Apoplexy
44%
Biological Marker
37%
Brain Ischemia
19%
Carbon Monoxide Intoxication
18%
Cell Count
20%
Community-Acquired Pneumonia
18%
Computed Tomography Angiography
24%
Computer Assisted Tomography
60%
COVID-19
55%
Diagnostic Accuracy
28%
Digital Subtraction Angiography
18%
Ectrodactyly
18%
Emergency Department
100%
Esophagus
21%
Foreign Body
37%
Gabexate Mesilate
18%
Gastrointestinal Bleeding
18%
Hemoperitoneum
18%
Hyperbaric Medicine
18%
Ingestion
29%
Intensive Care Unit
39%
Laparotomy
28%
Leukocyte
23%
Lymphocyte
59%
Medicine
18%
Meta-Analysis
98%
Monocyte
95%
Network Meta-Analysis
37%
Neutrophil
61%
Odds Ratio
41%
Percutaneous Thrombectomy
30%
Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
18%
Randomized Clinical Trial
37%
Randomized Controlled Trial
34%
Scoring System
41%
Sensitivity and Specificity
24%
Sepsis
55%
Serositis
27%
Spleen Rupture
18%
Symptom
30%
Systematic Review
20%
Systematic Review with Meta-Analysis
18%
Tachypnea
18%
Thorax Radiography
21%
Thromboembolism
18%
Tranexamic Acid
18%
Upper Respiratory Tract Infection
18%
Weakness
27%
Nursing and Health Professions
Acute Cholecystitis
37%
Acute Coronary Syndrome
18%
Area under the Curve
10%
Atrial Fibrillation
18%
Biological Marker
11%
Bleeding
8%
Blood Pressure
7%
Blood Pressure Monitor
18%
Carbon Monoxide Intoxication
18%
Cholecystitis
18%
Clinical Outcome
7%
Computer Assisted Tomography
18%
Confidence Interval
30%
Decision Trees
18%
Diagnosis
8%
Disease
18%
Electrocardiogram
13%
Emergency Ward
37%
Endoscopic Retrograde Cholangiopancreatography
18%
Gabexate Mesilate
18%
Gastrointestinal Hemorrhage
18%
Heart Arrest
18%
Hepatitis B
18%
Hospitalization
16%
Hyperbaric Medicine
18%
Imaging
18%
Inflammation
20%
Intensive Care Unit
20%
Length of Stay
20%
Logistic Regression Analysis
10%
Meta Analysis
43%
Morphine
18%
Network Meta-Analysis
37%
Neuromuscular Electrical Stimulation
8%
Neutrophil Lymphocyte Ratio
21%
Odds Ratio
25%
Pancreatitis
18%
Pilot Study
18%
Practice Guideline
9%
Predictive Value
10%
Respiratory Tract Infection
11%
Resuscitation
18%
Scoring System
9%
Sepsis
18%
Systematic Review
20%
Systematic Review with Meta-Analysis
18%
Tranexamic Acid
18%
Upper Respiratory Tract Infection
18%
Ward
18%
Weakness
18%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Cholecystitis
18%
Acute Coronary Syndrome
22%
Acute Heart Infarction
6%
Acute Kidney Failure
37%
Acute Lung Injury
10%
Adverse Event
7%
Antiplatelet
10%
Atrial Fibrillation
18%
Biological Marker
26%
Bleeding
9%
Brain Ischemia
19%
C Reactive Protein
11%
Carbon Monoxide Poisoning
18%
CD71 Antigen
9%
Cholecystitis
18%
Clinical Trial
18%
Coronavirinae
18%
Creatine Kinase
6%
Cytokine
7%
Disease
26%
Divalent
9%
Ferritin
12%
Ferroportin
9%
Gabexate Mesilate
18%
Gastrointestinal Hemorrhage
18%
Hepatitis B
18%
Hepatitis B Virus
18%
Hepcidin
18%
Hypothyroidism
18%
Ibuprofen
18%
Infection
20%
Inflammation
15%
Interleukin 6
8%
Major Adverse Cardiac Event
6%
Memory Disorder
6%
Mesenteric Ischemia
18%
Monotherapy
18%
Morphine
18%
Organ Dysfunction Score
5%
Pancreatitis
18%
Paracetamol
18%
Pericardial Effusion
7%
Prospective Study
19%
Random Effects Model
6%
Randomized Clinical Trial
37%
Randomized Controlled Trial
49%
Sepsis
18%
Thromboembolism
18%
Tranexamic Acid
18%
Transient Ischemic Attack
18%
